Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Silence Therapeutics appoints Thomas Christely

September 21, 2011 Research and Development appointment, research and development

UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …
Appointment

Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme

September 20, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates

A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …
News
Press release

Roche to show new cancer data at European congress

September 20, 2011 Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
News
Merck Serono

Merck licences new MS drug

September 19, 2011 Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301

Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
News

Melanoma: new treatments and hopes

September 19, 2011 Research and Development advanced melanoma, melanoma, skin cancer

It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …
Feature
GSK McLaren

McLaren alliance to turbocharge GSK research

September 16, 2011 Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news

GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
News

UK-funded science research must be made more accessible, says minister

September 16, 2011 Medical Communications, Research and Development UK science

Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …
News

Positive results for phase II malaria vaccine

September 16, 2011 Research and Development malaria, malaria vaccine

Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …
News

Designing clinical trials for the real world

September 15, 2011 Research and Development clinical trials

A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …
Feature

First Paediatric Use Marketing Authorisation Granted

September 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …
News
Press release
Merck & Co

Merck collaborates with China-based genomics specialist BGI

September 14, 2011 Research and Development BGI, Merck & Co, biomarkers, genomics

Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …
News
US Food and Drug Administration

FDA unveils changes to cancer drug review

September 14, 2011 Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs

The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …
News
GlaxoSmithKline

GSK-Amicus start late-stage trials of Fabry disease treatment

September 14, 2011 Research and Development Amicus Therapeutics, Fabry disease, GSK

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …
News

Novartis loses global development head to Gates Foundation

September 14, 2011 Research and Development Bill and Melinda Gates Foundation, Novartis, appointment

Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …
News

The recast of the Restriction of Hazardous Substances (RoHS) Directive

September 13, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …
News
Press release
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026